Teva Announces Launch of a Generic Version of Letairis® (ambrisentan) Tablets in the United States
Go back to Teva Announces Launch of a Generic Version of Letairis® (ambrisentan) Tablets in the United States| TEVA PHARMACEUTICAL INDUSTRIES (NYSE: TEVA) | Delayed: 34.22 +1.01 (3.04%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $33.21 | 52 Week High | $66.55 | |||
| Open | $33.32 | 52 Week Low | $37.82 | |||
| Day High | $34.59 | P/E | N/A | |||
| Day Low | $33.16 | EPS | $0.00 | |||
| Volume | 7,249,288 | |||||
| TEVA PHARMACEUTICAL INDUSTRIES (NYSE: TEVA) | Delayed: 34.22 +1.01 (3.04%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $33.21 | 52 Week High | $66.55 | |||
| Open | $33.32 | 52 Week Low | $37.82 | |||
| Day High | $34.59 | P/E | N/A | |||
| Day Low | $33.16 | EPS | $0.00 | |||
| Volume | 7,249,288 | |||||
